# | Title | Journal | Year | Citations |
---|
1 | Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients | Radiotherapy and Oncology | 2009 | 2,607 |
2 | Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology | Radiotherapy and Oncology | 2006 | 1,387 |
3 | Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆ (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV | Radiotherapy and Oncology | 2005 | 1,315 |
4 | Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review | Radiotherapy and Oncology | 2003 | 969 |
5 | Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study | Radiotherapy and Oncology | 2005 | 867 |
6 | The relevance of tumour pH to the treatment of malignant disease | Radiotherapy and Oncology | 1984 | 858 |
7 | Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck | Radiotherapy and Oncology | 1996 | 795 |
8 | Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix | Radiotherapy and Oncology | 1993 | 762 |
9 | Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck | Radiotherapy and Oncology | 1996 | 710 |
10 | Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer | Radiotherapy and Oncology | 2011 | 649 |
11 | Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy | Radiotherapy and Oncology | 1992 | 641 |
12 | CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines | Radiotherapy and Oncology | 2003 | 611 |
13 | The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study | Radiotherapy and Oncology | 1999 | 607 |
14 | Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines | Radiotherapy and Oncology | 2014 | 585 |
15 | Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma | Radiotherapy and Oncology | 2005 | 583 |
16 | CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma | Radiotherapy and Oncology | 2015 | 576 |
17 | Oxygenation predicts radiation response and survival in patients with cervix cancer | Radiotherapy and Oncology | 1998 | 568 |
18 | Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009) | Radiotherapy and Oncology | 2010 | 546 |
19 | Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site | Radiotherapy and Oncology | 2011 | 534 |
20 | Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer | Radiotherapy and Oncology | 1989 | 528 |
21 | Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study | Radiotherapy and Oncology | 2016 | 527 |
22 | A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma | Radiotherapy and Oncology | 2012 | 525 |
23 | A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85 | Radiotherapy and Oncology | 1998 | 523 |
24 | The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway | Radiotherapy and Oncology | 2004 | 519 |
25 | Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome | Radiotherapy and Oncology | 1999 | 518 |
26 | The radiotherapeutic injury – a complex ‘wound’ | Radiotherapy and Oncology | 2002 | 518 |
27 | Pathogenetic mechanisms in radiation fibrosis | Radiotherapy and Oncology | 2010 | 498 |
28 | Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer | Radiotherapy and Oncology | 2000 | 490 |
29 | Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer | Radiotherapy and Oncology | 2007 | 475 |
30 | Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial | Radiotherapy and Oncology | 1997 | 474 |
31 | A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer | Radiotherapy and Oncology | 1997 | 469 |
32 | Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy | Radiotherapy and Oncology | 2004 | 469 |
33 | Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells | Radiotherapy and Oncology | 2009 | 463 |
34 | The radioresponsiveness of human tumours and the initial slope ofthe cell survival curve | Radiotherapy and Oncology | 1984 | 462 |
35 | ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer | Radiotherapy and Oncology | 2015 | 462 |
36 | Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial | Radiotherapy and Oncology | 1999 | 461 |
37 | Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases | Radiotherapy and Oncology | 1986 | 460 |
38 | Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial | Radiotherapy and Oncology | 2005 | 452 |
39 | Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities | Radiotherapy and Oncology | 2014 | 451 |
40 | Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer | Radiotherapy and Oncology | 2012 | 445 |
41 | MRI/linac integration | Radiotherapy and Oncology | 2008 | 444 |
42 | 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-upOn behalf of the Bone Pain Trial Working Party | Radiotherapy and Oncology | 1999 | 427 |
43 | Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy | Radiotherapy and Oncology | 2007 | 427 |
44 | Optimization of stationary and moving beam radiation therapy techniques | Radiotherapy and Oncology | 1988 | 425 |
45 | CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines | Radiotherapy and Oncology | 2015 | 425 |
46 | Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials | Radiotherapy and Oncology | 2013 | 413 |
47 | Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy/s | Radiotherapy and Oncology | 2017 | 410 |
48 | Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach | Radiotherapy and Oncology | 2013 | 408 |
49 | Treatment of a first patient with FLASH-radiotherapy | Radiotherapy and Oncology | 2019 | 406 |
50 | Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A systematic review and meta-analysis | Radiotherapy and Oncology | 2011 | 404 |